+1 650 843 5528 jraab@cooley.com
Jennifer Raab is a special counsel in Cooley's life sciences practice group, having joined in 2011.
Download full bio
AveXis – $95 Million IPO
Cour and Takeda Partner to Treat Celiac Disease
Axovant Completes $362 Million IPO
Aduro Completes $137 Million IPO
Ascendis Pharma closes $124 million IPO
View all
Life Sciences Corporate Partnering & Licensing
Life Sciences
University of California, Berkeley School of Law (Boalt Hall)JD, 2009
University of California, Los AngelesBS, with departmental honors, Biochemistrydepartmental honors, 2006
Jazz Pharmaceuticals Strikes Strategic Collaboration and Option Agreement with ImmunoGen September 12, 2017
Audentes Therapeutics – $85 Million IPO July 29, 2016
Cour and Takeda Partner to Treat Celiac Disease December 10, 2015
California Bar Association
+1 650 843 5528 office +1 650 849 7400 fax jraab@cooley.com
3175 Hanover StreetPalo Alto, CA 94304-1130